The estimated Net Worth of Russell L Carson is at least $797 million dollars as of 28 September 2015. Mr. Carson owns over 675,000 units of Select Medical stock worth over $3,018,465 and over the last 21 years he sold SEM stock worth over $794,023,279. In addition, he makes $256,400 as Lead Independent Director at Select Medical.
Russell has made over 21 trades of the Select Medical stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 675,000 units of SEM stock worth $25,353,000 on 28 September 2015.
The largest trade he's ever made was selling 7,762,001 units of Select Medical stock on 16 November 2006 worth over $91,203,512. On average, Russell trades about 570,946 units every 76 days since 2003. As of 28 September 2015 he still owns at least 89,014 units of Select Medical stock.
You can see the complete history of Mr. Carson stock trades at the bottom of the page.
Russell L. Carson is Lead Independent Director of the Company. He has served as a director of Select since February 1997, and became a director of the Company on February 25, 2005 Mr. Carson is Chairman of The Carson Family Charitable Trust. In 2015, the Board of Directors elected Mr. Carson to serve as Lead Director. He co-founded Welsh, Carson, Anderson & Stowe in 1978 and focused on healthcare investments. Mr. Carson has been a founding general partner of Welsh, Carson, Anderson & Stowe since 1979. Welsh, Carson, Anderson & Stowe has created 17 institutionally funded limited partnerships with total capital of more than $25 billion and has invested in more than 250 companies. Before co-founding Welsh, Carson, Anderson & Stowe, Mr. Carson was employed by Citicorp Venture Capital Ltd., a subsidiary of Citigroup, Inc., and served as its Chairman and Chief Executive Officer from 1974 to 1978.
As the Lead Independent Director of Select Medical, the total compensation of Russell Carson at Select Medical is $256,400. There are 15 executives at Select Medical getting paid more, with Robert Ortenzio having the highest compensation of $7,746,020.
Russell Carson is 76, he's been the Lead Independent Director of Select Medical since 2015. There are 2 older and 21 younger executives at Select Medical. The oldest executive at Select Medical Holdings Corporation is Rocco A. Ortenzio, 88, who is the Co-Founder & Vice Chairman.
Russell's mailing address filed with the SEC is C/O WELSH, CARSON, ANDERSON & STOWE, 599 LEXINGTON AVE., SUITE 1800, NEW YORK, NY, 10022.
Over the last 15 years, insiders at Select Medical have traded over $775,614,410 worth of Select Medical stock and bought 444,289 units worth $6,141,552 . The most active insiders traders include Russell L Carson, Jonathan M Rather et Patrick J Welsh. On average, Select Medical executives and independent directors trade stock every 24 days with the average trade being worth of $9,819,895. The most recent stock trade was executed by Robert A Ortenzio on 8 April 2024, trading 50,000 units of SEM stock currently worth $1,495,000.
select medical encompasses four areas of expertise: long-term acute care, inpatient medical rehabilitation, outpatient physical therapy and contract therapy, all of which are delivered and supported by nearly 40,000 talented colleagues across the united states. despite its record growth, select medical remains true to its founding principles of clinical quality and operational excellence, which have been a top priority since day one. regardless of size or scope, the select medical team remains devoted to helping others and achieving outcomes that improve quality of life. our vision • the select medical way is to put the patient first • the select medical way is to help improve quality of life for the community in which we live and work • the select medical way is to be open to and welcoming of new ideas from all levels of the organization to continually improve • the select medical way is to attract, train, and retain the best possible staff • the select medical way is to st
Select Medical executives and other stock owners filed with the SEC include: